Last Posted: May 31, 2019
- Grail, a deep-pocketed startup, shows ‘impressive,’ if early, results for cancer blood test
M Herper, Stat News, May 31, 2019 - Promises and Pitfalls of Using Liquid Biopsy for Precision Medicine.
Rossi Giovanna et al. Cancer research 2019 May - Next generation sequencing data for use in risk assessment.
Merrick B Alex et al. Current opinion in toxicology 2019 Dec 1818-26 - Making the invisible visible: New method opens unexplored realms for liquid biopsies
Michigan Medicine, Eureka Alert, May 3, 2019 - IQN path ASBL report from the first European cfDNA consensus meeting: expert opinion on the minimal requirements for clinical ctDNA testing.
Deans Zandra C et al. Virchows Archiv : an international journal of pathology 2019 Apr - Journal of Translational Medicine advances in Translational Genomics and Genetics Era.
Liu Wei et al. Journal of translational medicine 2019 Apr 17(1) 134 - Continuously capturing circulating cancer cells
RP Kulkarni, Science Translational Medicine, April 24, 2019 - Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy.
Zeng Chang et al. Cancer communications (London, England) 2019 Mar 39(1) 12 - Utility of cfDNA Fragmentation Patterns in Designing the Liquid Biopsy Profiling Panels to Improve Their Sensitivity.
Ivanov Maxim et al. Frontiers in genetics 2019 10194 - Potential Utility of Liquid Biopsy as a Diagnostic and Prognostic Tool for the Assessment of Solid Tumors: Implications in the Precision Oncology.
Mathai Roshni Ann et al. Journal of clinical medicine 2019 Mar 8(3)
.png)
No hay comentarios:
Publicar un comentario